Effect of formoterol on eosinophil trans-basement membrane migration induced by interleukin-8-stimulated neutrophils

International Archives of Allergy and Immunology

Volumn 161, Issue , 2013, Pages 10-15

  Kawashima, Akiko ^a   Suzuki, Tomoko ^a   Nishihara, Fuyumi ^a   Kobayashi, Takehito ^a   Takaku, Yotaro ^b   Nakagome, Kazuyuki ^a   Soma, Tomoyuki ^a   Hagiwara, Koichi ^a   Kanazawa, Minoru ^a   Nagata, Makoto ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b SAITAMA CARDIOVASCULAR AND RESPIRATORY CENTER   (Japan)

Author keywords

Asthma; Eosinophil; Formoterol; Interleukin 8; Neutrophil; Trans basement membrane migration

Indexed keywords

BUDESONIDE; EOSINOPHIL PEROXIDASE; FORMOTEROL; INTERLEUKIN 8; MATRIGEL; ETHANOLAMINE DERIVATIVE;

ADULT; BASEMENT MEMBRANE; BLOOD SAMPLING; CELL ISOLATION; CELL MIGRATION; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; ENZYME ASSAY; EOSINOPHIL; FEMALE; HUMAN; INCUBATION TEMPERATURE; INCUBATION TIME; MALE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; TRANS BASEMENT MEMBRANE MIGRATION; ARTICLE; CELL CULTURE; IMMUNOLOGY; LEUKOCYTE ACTIVATION; NEUTROPHIL CHEMOTAXIS; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

BASEMENT MEMBRANE; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; EOSINOPHILS; ETHANOLAMINES; HUMANS; INTERLEUKIN-8; NEUTROPHIL ACTIVATION; NEUTROPHILS; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

MLCS; MLOWN;

EID: 84880544791     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000350335     Document Type: Conference Paper

References (23)

1. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ: Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-178.
2. Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma: summary report 2007. J Allergy Clin Immunol 2007; 120:S94-S138.
3. Harrison TW, Oborne J, Newton S, Tatters-field AE: Doubling the dose of inhaled corti-costeroid to prevent asthma exacerbations: randomised controlled trial. Lancet 2004; 363: 271-275.
4. Green RH, Brightling CE, McKenna S, Harga-don B, Parker D, Bradding P, Wardlaw AJ, Pavord ID: Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360:1715-1721.
5. Spahn JD: Asthma biomarkers in sputum. Immunol Allergy Clin North Am 2012; 32: 387-399.
6. Wenzel SE, Schwartz LB, Langmack EL, Hal-liday JL, Trudeau JB, Gibbs RL, Chu HW: Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999; 160:1001-1008.
7. Gibson PG, Simpson JL, Saltos N: Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001; 119:1329-1336.
8. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID: Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002; 57:875-879.
9. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J 2003; 22:470-477.
10. Kikuchi S, Nagata M, Kikuchi I, Hagiwara K, Kanazawa M: Association between neutro-philic and eosinophilic inflammation in patients with severe persistent asthma. Int Arch Allergy Immunol 2005; 137(suppl 1):7-11.
11. Kikuchi I, Kikuchi S, Kobayashi T, Hagiwara K, Sakamoto Y, Kanazawa M, Nagata M: Eo-sinophil trans-basement membrane migration induced by interleukin-8 and neutro-phils. Am J Respir Cell Mol Biol 2006; 34:760-765.
12. Pauwels RA, Lofdahl CG, Postma DS, Tatters-field AE, O'Byrne P, Barnes PJ, Ullman A: Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337:1405-1411.
13. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, Tattersfield A: Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001; 164:1392-1397.
14. O'Byrne PM: Daily inhaled corticosteroid treatment should be prescribed for mild persistent asthma. Pro Am J Respir Crit Care Med 2005; 172:410-412.
15. Maneechotesuwan K, Essilfie-Quaye S, Meah S, Kelly C, Kharitonov SA, Adcock IM, Barnes PJ: Formoterol attenuates neutrophilic airway inflammation in asthma. Chest 2005; 128: 1936-1942.
16. Anderson P, Lotvall J, Linden A: Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro. Lung 1996; 174: 159-170.
17. Bowden JJ, Sulakvelidze I, McDonald DM: Inhibition of neutrophil and eosinophil adhesion to venules of rat trachea by beta 2-adren-ergic agonist formoterol. J Appl Physiol 1994; 77:397-405.
18. Kelly MM, O'Connor TM, Leigh R, Otis J, Gwozd C, Gauvreau GM, Gauldie J, O'Byrne PM: Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. J Allergy Clin Immunol 2010; 125:349-356 e313.
19. Pizzichini MM, Pizzichini E, Efthimiadis A, Chauhan AJ, Johnston SL, Hussack P, Maho-ny J, Dolovich J, Hargreave FE: Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am J Respir Crit Care Med 1998; 158:1178-1184.
20. Ito K, Herbert C, Siegle JS, Vuppusetty C, Hansbro N, Thomas PS, Foster PS, Barnes PJ, Kumar RK: Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma. Am J Respir Cell Mol Biol 2008; 39:543-550.
21. Gravett CM, Theron AJ, Steel HC, Tintinger GR, Cockeran R, Feldman C, Anderson R: Interactive inhibitory effects of formoterol and montelukast on activated human neutrophils. Eur Respir J 2010; 36:1417-1424.
22. Koyama S, Sato E, Masubuchi T, Takamizawa A, Kubo K, Nagai S, Isumi T: Procaterol inhibits IL-1beta-and TNF-alpha-mediated epithelial cell eosinophil chemotactic activity. Eur Respir J 1999; 14:767-775.
23. Tacon CE, Newton R, Proud D, Leigh R: Rhi-novirus-induced MMP-9 expression is dependent on Fra-1, which is modulated by for-moterol and dexamethasone. J Immunol 2012; 188:4621-4630.